Anya Biopharm Inc. (TPEX:7776)
Taiwan
· Delayed Price · Currency is TWD 30.80
+0.80 (2.67%)
At close: Apr 28, 2026
Anya Biopharm Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 150.75 | 290.22 | 11.46 | 2.07 |
| Short-Term Investments | 219.47 | 163.93 | - | - |
| Cash & Short-Term Investments | 370.22 | 454.15 | 11.46 | 2.07 |
| Cash Growth | -18.48% | 3864.28% | 454.50% | - |
| Accounts Receivable | 11.88 | 3.4 | 0.17 | 0.56 |
| Other Receivables | 5.02 | 2.8 | - | 0.75 |
| Receivables | 16.9 | 6.2 | 0.17 | 1.31 |
| Prepaid Expenses | 4.61 | 0.85 | - | 1.46 |
| Other Current Assets | 0.97 | 0.68 | 1.41 | 0.76 |
| Total Current Assets | 392.7 | 461.88 | 13.03 | 5.6 |
| Property, Plant & Equipment | 8.74 | 9.15 | 1.72 | 2.5 |
| Other Intangible Assets | 5.99 | 5.08 | 5.08 | 0.6 |
| Other Long-Term Assets | 6.46 | 5.22 | 2.4 | 2.86 |
| Total Assets | 413.87 | 481.32 | 22.23 | 11.56 |
| Accrued Expenses | 6.99 | 6.47 | 1.85 | 1.38 |
| Short-Term Debt | - | - | 102.01 | 63.28 |
| Current Portion of Leases | 0.12 | 0.17 | 0.95 | 0.82 |
| Current Unearned Revenue | - | 3.23 | - | - |
| Other Current Liabilities | 1.08 | 1.24 | 0.61 | 0.36 |
| Total Current Liabilities | 8.19 | 11.11 | 105.41 | 65.84 |
| Long-Term Leases | 2.83 | 3.25 | 0.08 | 0.9 |
| Total Liabilities | 11.02 | 14.36 | 105.49 | 66.74 |
| Common Stock | 491.02 | 491.02 | 8.77 | 8.77 |
| Additional Paid-In Capital | 14.82 | 14.82 | 16.38 | 16.38 |
| Retained Earnings | -102.85 | -38.83 | -108.39 | -80.31 |
| Comprehensive Income & Other | -0.16 | -0.13 | -0.04 | -0.04 |
| Total Common Equity | 402.83 | 466.89 | -83.28 | -55.19 |
| Minority Interest | 0.02 | 0.08 | 0.01 | 0.02 |
| Shareholders' Equity | 402.85 | 466.97 | -83.26 | -55.18 |
| Total Liabilities & Equity | 413.87 | 481.32 | 22.23 | 11.56 |
| Total Debt | 2.96 | 3.41 | 103.03 | 65 |
| Net Cash (Debt) | 367.26 | 450.73 | -91.58 | -62.93 |
| Net Cash Growth | -18.52% | - | - | - |
| Net Cash Per Share | 7.48 | 13.62 | -40.16 | -27.60 |
| Filing Date Shares Outstanding | 49.1 | 49.1 | 8.77 | 2.28 |
| Total Common Shares Outstanding | 49.1 | 49.1 | 8.77 | 2.28 |
| Working Capital | 384.51 | 450.77 | -92.39 | -60.24 |
| Book Value Per Share | 8.20 | 9.51 | -9.50 | -24.21 |
| Tangible Book Value | 396.84 | 461.8 | -88.36 | -55.79 |
| Tangible Book Value Per Share | 8.08 | 9.41 | -10.07 | -24.47 |
| Machinery | 4.18 | 2.69 | 1 | 0.94 |
| Leasehold Improvements | 3.46 | 3.8 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.